From www.mobihealthnews.com - November 14, 2018 2:26 AM

The Omnipod Dash Insulin Management System will initially be controlled using a dedicated Galaxy smartphone, but could eventually integrate with personal devices as well.

Samsung Galaxy smartphones will be serving as the controlling device for Billerica, Massachusetts-based Insulet Corporation’s tubeless insulin pump devices, the two companies announced today.

Initially, Insulet’s recently FDA-cleared Omnipod Dash Insulin Management System will only speak with an app run on a locked-down Galaxy smartphone provided to patients alongside the system itself. However, according to Dr. David Rhew, chief medical officer, VP and general manager of Samsung’s enterprise healthcare division, the long-term plan is to enable users to manage and administer their insulin using their own personal Galaxy smartphones, thanks in part to Samsung’s hardware and software-level mobile security platform.